Mammography screening in three Finnish residential areas: Comprehensive population-based study of breast cancer incidence and incidence-based mortality 1976-2009

British Journal of Cancer

Volumn 112, Issue 5, 2015, Pages 918-924

  Parvinen, I ^a   Heinavaara S ^b   Anttila, A ^b   Helenius, H ^a   Klemi, P ^a   Pylkkanen L ^a,c  

^a UNIVERSITY OF TURKU   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

^c Cancer Society of Finland   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; FEMALE; FINLAND; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MIDDLE AGED; POPULATION RESEARCH; PRIORITY JOURNAL; RESIDENTIAL AREA; VERY ELDERLY; BREAST NEOPLASMS; EARLY DIAGNOSIS; MASS SCREENING; MORTALITY; PROCEDURES; STATISTICS AND NUMERICAL DATA; SURVIVAL; URBAN POPULATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FINLAND; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; SURVIVAL ANALYSIS; URBAN POPULATION;

EID: 84928698339     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.642     Document Type: Article

References (51)

1. Addictionlink (2014) Alcohol use in Finland. Available from URL http://www.paihdelinkki.fi/articles/111-alcohol-use-in-finland (in Finnish) [accessed July 6].
2. Allen MD, Thomas GJ, Clark S, Dawoud MM, Vallat S, Payne SJ, Gomm JJ, Dreger SA, Dickinson S, Edwards DR, Pennington CJ, Sestak I, Cuzick J, Marshall JF, Hart IR, Jones JL (2014) Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of avb6 integrin in DCIS identifies high-risk patients and predicts recurrence. Clin Cancer Res 20: 344-357.
3. Allgood PC, Warwick J, Warren RML, Day NE, Duffy SW (2008) A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer 98: 206-209.
4. Anttila A, Sarkeala T, Hakulinen T, Heinävaara S (2008) Impacts of the Finnish service screening programme on breast cancer rates. BMC Public Health 8: 38.
5. Autier P, Boniol M, Gavin A, Vatten LJ (2011) Breast cancer mortality in neighboring European cancers with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ 343: d441.
6. Autier P, Boniol M, LaVecchia C, Vatten L, Gavin A, Hénry C, Heanue M (2010) Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ 341: c3620.
7. Bleyer A, Welch HG (2012) Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 367: 1998-2005.
8. Broeders M, Moss S, Nyström L, Njor S, Jonsson H, Paap E, Massat N, Duffy S, Lynge E, Paci E. Euroscreen Working Group (2012) The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies. J Med Screen 19: 14-25.
9. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, MvGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA. ICBP Module 1 Working Group (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007. (The International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377: 127-138.
10. Cuzick J, Sestak I, Pinder SE, Ellis IO, Forsyth S, Bundred NJ, Forbes JF, Bishop H, Fentiman IS, George WD (2011) Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol 12: 21-29.
11. Duffy SW, Agbaje O, Tabár L, Vitak B, Bjurstam N, Björneld L, Myles JP, Warwic J (2005) Estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res 7: 258-265.
12. Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen TH, Yen AM, Smith RA (2010) Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 17: 25-30.
13. Fielder HM, Warwick J, Brook D, Gower-Thomas K, Cuzick L, Monypenny I, Duffy SW (2004) A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen 11: 194-198.
14. Finnish Cancer Registry (2014) Cancer research and statistics information. Available from URL https://cancer-fi.directo.fi/syoparekisteri/en/?x56215626=99682018 (in Finnish) [accessed April 14].
15. Gabe R, Tryggvadottir L, Sigfusson BF, Olafsdóttir GH, Sigurdsson K, Duffy SW (2007) A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol 48: 948-955.
16. GLOBOCAN 2012 (2014) Estimated cancer incidence, mortality and prevalence worldwide in 2012. Available from URL globocan.iarc.fr [accessed April 14].
17. Gorini G, Zappa M, Miccinesi G, Paci E, Costantini AS (2004) Breast cancer mortality trends in two areas of the province of Florence, Italy, where screening programs started in the 1970 and 1990s. Br J Cancer 90: 1780-1783.
18. Gøtzsche PC, Jørgensen KJ, Zahl PH, Maehlen J (2012) Why mammography screening has not lived up to expectations from the randomised trials. Cancer Causes Control 23: 15-21.
19. Heinävaara S, Sarkeala T, Anttila A (2014) Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland. Br J Cancer 111: 1463-1468.
20. Hellquist BN, Duffy SW, Abdsaleh S, Björneld L, Bodás P, Tabár L, Viták B, Zackrisson S, Nyström L, Jonsson H (2011) Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish mammography screening in Young Women (SCRY) cohort. Cancer 117: 714-722.
21. Hofvind S, Ursin G, Tretli S, Sebuødegård S, Møller B (2013) Breast cancer mortality in participants of the Norwegian breast cancer screening program. Cancer 119: 3106-3112.
22. Immonen-Räihä P, Kauhava L, Parvinen I, Holli K, Kronqvist P, Pylkkänen L, Helenius H, Kaljonen A, Räsänen O, Klemi PJ (2005) Mammographic screening reduces risk of breast carcinoma recurrence. Cancer 103: 474-482.
23. Independent UK Panel on Breast Cancer Screening (2012) The benefits and harms of breast cancer screening: an independent review. Lancet 380: 1778-1786.
24. Klemi PJ, Parvinen I, Pylkkänen L, Kauhava L, Immonen-Räihä P, Räsänen O, Helenius H (2003) Significant improvement in breast cancer survival through population-based mammography screening. Breast 12: 308-313.
25. Lund E, Mode N, Wasseth M, Thalabard JC (2013) Overdiagnosis of breast cancer in the Norwegian Breast Cancer Screening Program estimated by the Norwegian Women and Cancer cohort study. BMC Cancer 13: 614.
26. Miller AB, To T, Baines CJ, Wall C (2002) The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 137: 305-312.
27. Monticciolo D, Monsees B (2013) Effect of screening mammography on breast cancer incidence (correspondence). N Engl J Med 367: 677-679.
28. Moss S (2005) Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res 7: 230-234.
29. Moss SM, Nyström L, Jonsson H, Paci E, Lynge E, Njor S, Broeders M. (Euroscreen Working Group) (2012) The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies. J Med Screen 19: 26-32.
30. Nickson C, Mason KE, English DR, Kavanagh AM (2012) Mammographic screening and breast cancer mortality: a case-control study and meta-analysis. Cancer Epidemiol Biomarkers Prev 21: 1479-1488.
31. NORDCAN database (2014) Nordic tool for cancer information. Available from URL http://www-dep.iarc.fr/NORDCAN/english/frame.asp [accessed April 14].
32. Otto SJ, Fracheboud J, Verbeek AL, Boer R, Reijerink-Verheij JC, Otten JD, Broders MJ, de Koning HJ (2012) Mammography screening and risk of breast cancer death: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 21: 66-73.
33. Parvinen I, Chiu S, Pylkkänen L, Klemi P, Immonen-Räihä P, Kauhava L, Malila N, Hakama M (2011) Effects of annual vs triennial mammography interval on breast cancer incidence and mortality in ages 40-49 in Finland. Br J Cancer 105: 1388-1391.
34. Parvinen I, Helenius H, Pylkkänen L, Anttila A, Immonen-Räihä P, Kauhava L, Räsänen O, Klemi PJ (2006) Service screening mammography reduces breast cancer mortality among elderly women in Turku. J Med Screen 13: 34-40.
35. Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, Paci E. Euroscreen Working Group (2012) Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 19: 42-56.
36. Puliti D, Zappa M. Breast cancer screening: are we seeing the benefit? (2012) BMC Med 10: 106.
37. Roder D, Houssami N, Farshid G, Gill G, Luke C, Downey P, Beckmann K, Iosifidis P, Grieve L, Williamson L (2008) Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat 108: 409-416.
38. Salmi T, Paldán M, Klaukka T (2004) The use of hormone replacement therapy has decreased in all parts of Finland. Finnish Med J 59: 1042-1045.
39. Sarkeala T, Heinävaara S, Anttila A (2008a) Organised mammography screening reduces breast cancer mortality: a cohort study from Finland. Int J Cancer 122: 614-619.
40. Sarkeala T, Heinävaara S, Anttila A (2008b) Breast cancer mortality with varying invitational policies in organised mammography. Br J Cancer 98: 641-645.
41. Sarkeala T, Näveri T, Malila N, Anttila A (2013) Performance of population-based breast cancer screening in Finland in 1992-2009. Finnish Med J 68: 225-231.
42. Sarkeala T (2008) Performance and effectiveness of organised breast cancer screening in Finland. Acta Oncol 47: 1618.
43. Seigneurin A, Francois O, Labarère J, Oudeville P, Monlong J, Colonna M (2011) Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry data. BMJ 343: d7017.
44. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
45. Statistics Finland (2014) Number of births fell further. Available from URL http://tilastokeskus.fi/til/synt/2013/synt-2013-2014-04-08-tie- 001-en.html (in Finnish) [accessed July 6].
46. Tabár L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, Chiu SY, Chen SL, Fann JC, Rosell J, Fohlin H, Smith RA, Duffy SW (2011) Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 260: 658-663.
47. Ursin G (2012) Mammographic screening debate on study design: a need to move the field forward. BMC Med 10: 164.
48. Weedon-Fekjaer H, Romundstad PR, Vatten LJ (2014) Modern mammography screening and breast cancer mortality: population study. BMJ 348: g3701.
49. Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD (2012) The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 36: 237-248.
50. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP (2006) Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ 331: 689-692.
51. Zahl PH, Strand BH, Maehlen J (2004) Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 328: 921-924.